TipRanks
Infant Bacterial Therapeutics (SE:IBT.B)
:IBT.B
IBT.B
Infant Bacterial Therapeutics AB
RESEARCH TOOLSreports
Want to see SE:IBT.B full AI Analyst Report?

Infant Bacterial Therapeutics AB (IBT.B) Revenue

0 Followers
StatisticsRevenue

Infant Bacterial Therapeutics AB Revenue

Infant Bacterial Therapeutics AB had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Infant Bacterial Therapeutics AB had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
kr0
Employees
6
Market Cap
kr926.83M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
―-4.00K-100.00%
Dec 31, 2024
4.00K-73.00K-94.81%
Dec 31, 2023
77.00K65.00K+541.67%
Dec 31, 2022
12.00K―+∞%
Dec 31, 2021
―――
Dec 31, 2020
―――
Dec 31, 2019
―――
Dec 31, 2018
―-238.00K-100.00%
Dec 31, 2017
238.00K――